Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction: a substudy of the CONDI-2/ERIC-PPCI randomized controlled trial

Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury

(2019) Sean M. Davidson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry

(2019) Rossella Marcucci et al.   PLoS One

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury

(2019) Nancy Schanze et al.   Frontiers in Immunology

Co‐morbidities and co‐medications as confounders of cardioprotection ‐ does it matter in the clinical setting?

(2019) Petra Kleinbongard et al.   BRITISH JOURNAL OF PHARMACOLOGY

Impaired Spontaneous/Endogenous Fibrinolytic Status as New Cardiovascular Risk Factor?

(2019) Diana A. Gorog et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

(2019) Derek J Hausenloy et al.   LANCET

Effect of remote ischaemic conditioning on platelet aggregation and platelet turnover

(2018) Nina Rise et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study

(2018) Mohamed Farag et al.   EUROPEAN HEART JOURNAL

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

(2017) Borja Ibanez et al.   EUROPEAN HEART JOURNAL

Ischemic Conditioning Attenuates Platelet-Mediated Thrombosis

(2017) Karin Przyklenk et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Effect of Remote Ischemic Preconditioning on Platelet Activation Induced by Coronary Procedures

(2016) Gaetano Antonio Lanza et al.   AMERICAN JOURNAL OF CARDIOLOGY

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery

(2016) Derek J. Hausenloy et al.   BASIC RESEARCH IN CARDIOLOGY

Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation

(2016) Michael V. Cohen et al.   CARDIOVASCULAR DRUGS AND THERAPY

Ischaemic conditioning and reperfusion injury

(2016) Derek J. Hausenloy et al.   Nature Reviews Cardiology

Cardioprotection by remote ischemic conditioning and its signal transduction

(2016) Petra Kleinbongard et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood

(2015) R. M. Bell et al.   CARDIOVASCULAR DRUGS AND THERAPY

Building the Case for Clopidogrel as a World Health Organization Essential Medicine: Figure.

(2015) Amisha Patel et al.  

Endogenous Fibrinolysis

(2015) Osita N. Okafor et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remote Ischemic Conditioning

(2015) Gerd Heusch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery

(2015) Derek J. Hausenloy et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery

(2015) Patrick Meybohm et al.   NEW ENGLAND JOURNAL OF MEDICINE

Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variable

(2015) Amy L Whitehead et al.   STATISTICAL METHODS IN MEDICAL RESEARCH

Building the Case for Clopidogrel as a World Health Organization Essential Medicine: Figure.

(2015) Amisha Patel et al.   Circulation-Cardiovascular Quality and Outcomes

CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated With Clopidogrel: A Meta-Analysis

(2014) M. J. Sorich et al.   Circulation-Cardiovascular Genetics

TEG and ROTEM: Technology and clinical applications

(2013) David Whiting et al.   AMERICAN JOURNAL OF HEMATOLOGY

Two Classes of Anti-Platelet Drugs Reduce Anatomical Infarct Size in Monkey Hearts

(2013) Xi-Ming Yang et al.   CARDIOVASCULAR DRUGS AND THERAPY

Effect of Remote Ischemic Preconditioning on Platelet Activation and Reactivity Induced by Ablation for Atrial Fibrillation

(2013) Alessandra Stazi et al.   CIRCULATION

Platelet-Derived Microparticles are Implicated in Remote Ischemia Conditioning in a Rat Model of Cerebral Infarction

(2013) Li-Yang Shan et al.   CNS Neuroscience & Therapeutics

Combined Cardioprotectant and Antithrombotic Actions of Platelet P2Y12 Receptor Antagonists in Acute Coronary Syndrome

(2013) Michael V. Cohen et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial

(2013) Matthias Thielmann et al.   LANCET

Effects of Remote Ischemic Preconditioning on the Coagulation Profile of Patients With Aneurysmal Subarachnoid Hemorrhage

(2013) Fernando Mayor et al.   NEUROSURGERY

Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis

(2012) François Roubille et al.   BASIC RESEARCH IN CARDIOLOGY

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

(2012) Sumeet Sharma et al.   EUROPEAN HEART JOURNAL

Platelet P2Y12 Blockers Confer Direct Postconditioning-Like Protection in Reperfused Rabbit Hearts

(2012) Xi-Ming Yang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Remote ischemic preconditioning reduces thrombus formation in the rat

(2012) D. M. RØPCKE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Remote Ischemic Conditioning: From Bench to Bedside

(2012) Shiang Yong Lim et al.   Frontiers in Physiology

Ischaemia–reperfusion injury impairs tissue plasminogen activator release in man

(2011) Christian M. Pedersen et al.   EUROPEAN HEART JOURNAL

Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease

(2011) I. Battipaglia et al.   HEART

Remote Ischemic Conditioning in Patients With Myocardial Infarction Treated With Primary Angioplasty

(2010) Kim Munk et al.   Circulation-Cardiovascular Imaging

Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI

(2010) Jessica L. Mega et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Remote ischemic preconditioning prevents systemic platelet activation associated with ischemia-reperfusion injury in humans

(2010) C. M. PEDERSEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

(2010) Hans Erik Bøtker et al.   LANCET

Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy

(2009) Alan R. Shuldiner   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Remote ischaemic preconditioning: underlying mechanisms and clinical application

(2008) D. J. Hausenloy et al.   CARDIOVASCULAR RESEARCH

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

(2008) Jessica L. Mega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Genetic Determinants of Response to Clopidogrel and Cardiovascular Events

(2008) Tabassome Simon et al.   NEW ENGLAND JOURNAL OF MEDICINE